Navigation Links
Iowa Staters talk biofuels, healthy oils and 'pharma crops' at AAAS meeting
Date:2/16/2008

AMES, Iowa Theres more to biofuels than the food vs. fuel debate and talk of the various technologies associated with biofuels production.

And so Steven Fales, a professor of agronomy and a member of the Science and Engineering Board of Iowa States Bioeconomy Institute, organized and moderated a three-hour symposium on Friday, Feb. 15, at the annual meeting of the American Association for the Advancement of Science in Boston.

The title of the discussion was, Energy, Agriculture, and People: Global Implications for Science and Policy.

We thought it would be appropriate to take a big picture view of issues regarding energy and agriculture that go beyond the science and technology, Fales said.

And so there were presentations about climate change, production of biofuel crops on marginal lands, the effects of biofuel production on the poor, the ethics of using agriculture for energy production and the politics associated with renewable energy.

Fales said the idea was to mirror the global theme of the annual meeting and acknowledge that biorenewable issues extend beyond energy into many other concerns of society.

Two other researchers with ties to Iowa State also made presentations during the AAAS annual meeting Feb. 14-18:

Robert Wisner, a recently retired University Professor of agricultural economics, addressed a 90-minute symposium on Friday, Feb. 15, titled, Drugs in our Corn Flakes" Our Health and the Economic Risks of Pharma and Industrial Crops.

Wisners talk addressed the economics of growing crops with medicinal traits engineered into them. Key economic issues include the risks of co-mingling medical drugs and industrial chemicals with the food supply and the alternatives for controlling that risk. But those arent the only economic issues he identified. Others were determining the real and long-term costs and benefits of pharma crops, identifying who gains from the crops and learning whether producing medicines and chemicals in non-food crops is more economical and less risky than using food crops. Wisner also noted several instances when unapproved genetically modified crops were found in food supplies. In those instances, Wisner said there were major disruptions in grain export markets, price impacts and very high public and private costs to purge the grain from the food system.

Linda Pollak, a research geneticist for the U.S. Department of Agriculture and a collaborative associate professor of agronomy at Iowa State, addressed a 90-minute symposium on Saturday, Feb. 16, titled, Crops for Health: Improving the Health-Promoting Properties of Food.

Pollaks message was that traditional plant breeding can be a tool to improve human health. Plant breeders, for example, have been able to reduce some of the problems with oils from soybeans, canola, sunflowers and corn. She said plant breeders have developed soybeans with lower levels of fatty acids to help reduce trans fats after processing. Breeders have also developed canola lines with safe levels of toxic erucic acid. And plant breeders have decreased saturated fats and increased monounsaturated fats in canola, sunflower and corn oils to reduce the risk of heart disease. And so Pollak argued traditional plant breeding can still develop better crops for healthier foods.


'/>"/>

Contact: Mike Krapfl
mkrapfl@iastate.edu
515-294-4917
Iowa State University
Source:Eurekalert

Related biology news :

1. Youre likely to order more calories at a healthy restaurant
2. Studies: Children obese due to a host of unhealthy pressures
3. New study shows Concord grape juice has a heart-healthy effect not yet reported with red wine
4. Gene, stem cell therapy only needs to be 50 percent effective to create a healthy heart
5. Insect gut detects unhealthy meal
6. Want healthy gums? Hit the dairy aisle
7. Bacteria from sponges make new pharmaceuticals
8. Researchers develop liquid crystal pharmaceuticals to fight cancer and other diseases
9. Biopharmaceutical infrastructure key to lower drug development costs
10. NMR researchers unlock hydrogens secrets to spot polymorphism in pharmaceuticals
11. Biotech Co. founded by UCLA Scientists to be acquired by Astellas, Pharma Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/14/2017)... -- IBM (NYSE: IBM ) is introducing several innovative partner ... developing collaboration between startups and global businesses, taking place in ... event, nine startups will showcase the solutions they have built ... France is one of ... 30 percent increase in the number of startups created between ...
(Date:5/6/2017)... RAM Group , Singaporean based ... in biometric authentication based on a novel  ... to perform biometric authentication. These new sensors are based on ... Ram Group and its partners. This sensor will have ... and security. Ram Group is a next generation ...
(Date:4/17/2017)... , April 17, 2017 NXT-ID, Inc. (NASDAQ: ... announces the filing of its 2016 Annual Report on Form 10-K ... Commission. ... 10-K is available in the Investor Relations section of the Company,s ... the SEC,s website at http://www.sec.gov . 2016 Year ...
Breaking Biology News(10 mins):
(Date:8/15/2017)... ... August 15, 2017 , ... Nanomedical Diagnostics ... biotherapeutics development, announces the launch of the new NHS Agile biosensor chip ... binding data for a wide range of molecules, including small and large molecules, ...
(Date:8/15/2017)... ... August 15, 2017 , ... Kenall, a ... downlights designed to stay tightly sealed and perform efficiently for years. The downlights ... location listings just aren't enough, such as: hospitals; behavioral health facilities; cleanrooms; containment ...
(Date:8/15/2017)... ... August 15, 2017 , ... JULABO USA introduces its new ... website makes it easy to navigate through the site whether you’re in the ... product information, educational industry content and visit the company’s social media accounts, all ...
(Date:8/14/2017)... New York, NY (PRWEB) , ... August 14, 2017 , ... ... Mobile in Clinical Trials event, which will take place on September 6, 2017 ... Daniel Karlin, MD , Head of Experimental Medicine, Informatics, and Regulatory Strategy, Pfizer ...
Breaking Biology Technology: